Skip to main content

Innovations for Tackling Tuberculosis in the Time of COVID-19 Proceedings of a Workshop (2022) / Chapter Skim
Currently Skimming:


Pages 165-172

The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.


From page 165...
... • How can we rapidly use the TB platform, such as contact investiga tion, in low- to middle-income countries to address COVID-19 and other airborne infections to prevent future pandemics?    • How can we ensure increased and sustained commitments to reach the UNHLM TB targets in high-burden countries, despite the chal lenges from COVID-19?
Read the entire page →
From page 166...
... 166 INNOVATIONS FOR TACKLING TUBERCULOSIS workshop series will be summarized in a proceedings -- in brief (Part One) and a full-length proceedings (Part Two)
Read the entire page →
From page 167...
... 11:40 AM Vaccines and Therapeutics Emilio Emini (Bill & Melinda Gates Foundation)
Read the entire page →
From page 168...
... 12:55 PM Wrap-up and Adjourn Gail Cassell, workshop co-chair Kenneth Castro, workshop co-chair WORKSHOP -- PART TWO TUESDAY, SEPTEMBER 14, 2021 11:00 AM–2:30 PM ET Workshop Opening 11:00 AM Welcome and Workshop Goals Peter Daszak, Chair, Forum on Microbial Threats, National Academy of Medicine; President, EcoHealth Alliance Lucica Ditiu, moderator, Stop TB Partnership 11:05 AM Sponsor Remarks  Jennifer Adams, Senior Deputy Assistant Administrator, Bureau for Global Health, United States Agency for International Development 11:20 AM Building a Tuberculosis-Free World: Progress Update Eric Goosby (University of California, San Francisco) 15 min Q&A Realities of Multidrug-Resistant TB and Challenges for TB Control Matteo Zignol (World Health Organization)
Read the entire page →
From page 169...
... 1:15 PM Enhancing Adherence, Infection Control Capacities, and Cost-Effectiveness Expansion and Improvements to Contact Tracing and Engagement: Mobile or Digital Platforms from the COVID-19 Pandemic Aamir Khan (IRD) Telehealth and Digital Adherence Technologies Bruce Thomas (The Arcady Group)
Read the entire page →
From page 170...
... 2:15 PM Reflections on Session 1 Lucica Ditiu 2:30 PM Adjourn WORKSHOP PART 2 WEDNESDAY, SEPTEMBER 15, 2021 11:00 AM–2:30 PM ET Session 2: Vaccines and Therapeutics 11:00 AM Welcome and Session Goals Kent Kester, moderator, Sanofi Pasteur 11:05 AM Using Existing Tools and New Technologies BCG Revaccination Alex Schmidt (Bill & Melinda Gates Medical Research Institute) Promising New Adjuvants and Late-Stage Clinical Development Vaccine Candidates Steve Reed (University of Washington; HDT Bio)
Read the entire page →
From page 171...
... What It Takes to Roll Out a New Treatment Regimen: Lessons from Drug-Resistant TB Adrian Thomas (Johnson & Johnson) Norbert Ndjeka (National Department of Health, Republic of South Africa)
Read the entire page →
From page 172...
...  Rebecca Katz (Georgetown University, Center for Global Health Science and Security)  Michael Callahan (Massachusetts General Hospital; United Therapeutics)
Read the entire page →

Key Terms

  • south africa
  • global health
  • bcg revaccination
  • economic analyses
  • future pandemics

  • pandemic preparedness
  • contact tracing
  • implementation challenges
  • hdt bio
  • global fund

  • melinda gates
  • global commons
  • immune mechanisms
  • treatment regimen
  • gates foundation

  • vaccine candidates
  • digital adherence
  • airborne infection
  • adherence technologies
  • georgetown university

  • consensus center
  • steve reed
  • income countries
  • innovative strategies


    • This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
    More information on Chapter Skim is available.